Postpartum pElvic Assisted Recovery With Leva
Part of paid clinical trials in Tampa, Florida.
- Sponsor
- University of South Florida
- Study ID
- NCT06609317
- Status
- Recruiting
Conditions
- Postpartum Pelvic Floor Function and Symptoms
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Digital therapeutic motion-based device — DEVICEThis intervention includes use of a digital therapeutic motion-based device for pelvic floor muscle training
Study Details
The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device. In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum. Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.
Key Dates
- Start date
- Apr 4, 2025
- Status verified
- Jul 2025
- Primary completion
- Nov 30, 2025
- Completion
- Feb 28, 2026
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: Device ArmParticipants in this arm will use a digital therapeutic motion-based device for postpartum pelvic floor muscle training
Primary Outcome Measure
Feasibility [ Time Frame: From enrollment to 6 months postpartum ]
Central Contacts
- Katie Propst, MD813-259-0655
- Maha Al Jumaily, MBBS813-259-8680
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of South Florida | Tampa | Florida | 33606 | Katie Propst, MD (PRINCIPAL_INVESTIGATOR) |
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | Lisa Hickman, MD (PRINCIPAL_INVESTIGATOR) |